Please login or sign up to post and edit reviews.
Closing the gaps in hormonal healthcare with Sylvia Kang from Mira
Podcast |
Found
Publisher |
TechCrunch
Media Type |
audio
Categories Via RSS |
Business
Entrepreneurship
News
Tech News
Technology
Publication Date |
Sep 10, 2024
Episode Duration |
00:43:54

Research is completely lacking when it comes to information about women’s hormonal health. Today’s guest is working to compile data and help women find the care they need. This week on Found, we’re talking to Sylvia Kang, the CEO and co-founder of Mira, a women’s health company that is providing home hormonal testing. They discuss the challenges on fundraising for women’s health startups, the importance of research to drive change and access in healthcare, and how Mira forged a new path by becoming FDA approved.

00:00 - Introduction and Overview of Women’s Hormonal Health01:45 - The Lack of Hormonal Health Data and Fertility Challenges05:11 - The Inspiration Behind Starting Mira07:30 - Early Feedback from Doctors and Investors10:58 - The Evolution of the Women’s Health Market13:25 - Overcoming the Lack of Scientific Research and Data Collection16:51 - Impact of COVID-19 on Mira’s Growth18:42 - Mira as a Cost-Effective Solution to Fertility Issues21:29 - Mira’s Expansion Beyond Fertility and into IVF25:02 - Utilizing AI to Personalize Hormonal Health Tracking28:35 - Sylvia’s Journey from Corporate to Entrepreneurship32:15 - Building a Female-Driven Company Culture at Mira34:49 - The Future of Women’s Health and Expanding Mira’s Impact

Found posts every Tuesday. Subscribe on Apple, Spotify or wherever you listen to podcasts to be alerted when new episodes drop. Check out the other TechCrunch podcast: Equity . Subscribe to Found to hear more stories from founders each

 

Connect with us:

Research is completely lacking when it comes to information about women’s hormonal health. Today’s guest is working to compile data and help women find the care they need. This week on Found, we’re talking to Sylvia Kang, the CEO and co-founder of Mira, a women’s health company that is providing home hormonal testing. They discuss the challenges on fundraising for women’s health startups, the importance of research to drive change and access in healthcare, and how Mira forged a new path by becoming FDA approved.

Research is completely lacking when it comes to information about women’s hormonal health. Today’s guest is working to compile data and help women find the care they need. This week on Found, we’re talking to Sylvia Kang, the CEO and co-founder of Mira, a women’s health company that is providing home hormonal testing. They discuss the challenges on fundraising for women’s health startups, the importance of research to drive change and access in healthcare, and how Mira forged a new path by becoming FDA approved.

00:00 - Introduction and Overview of Women’s Hormonal Health01:45 - The Lack of Hormonal Health Data and Fertility Challenges05:11 - The Inspiration Behind Starting Mira07:30 - Early Feedback from Doctors and Investors10:58 - The Evolution of the Women’s Health Market13:25 - Overcoming the Lack of Scientific Research and Data Collection16:51 - Impact of COVID-19 on Mira’s Growth18:42 - Mira as a Cost-Effective Solution to Fertility Issues21:29 - Mira’s Expansion Beyond Fertility and into IVF25:02 - Utilizing AI to Personalize Hormonal Health Tracking28:35 - Sylvia’s Journey from Corporate to Entrepreneurship32:15 - Building a Female-Driven Company Culture at Mira34:49 - The Future of Women’s Health and Expanding Mira’s Impact

Found posts every Tuesday. Subscribe on Apple, Spotify or wherever you listen to podcasts to be alerted when new episodes drop. Check out the other TechCrunch podcast: Equity . Subscribe to Found to hear more stories from founders each

 

Connect with us:

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review